Table 3 Comparison between patients treated ≤ 6 months before vaccination and those treated > 6 months before vaccination regarding HLN stratified by age group
Treated ≤ 6 months before vaccination | Treated > 6 months before vaccination | ||||||
|---|---|---|---|---|---|---|---|
Age group | HLN | No. | % | No. | % | Testa | p-value |
≤ 60 years | No HLN | 9 | 60 | 6 | 10 | – | – |
Grade 1 | 4 | 26.7 | 24 | 40 | |||
Grade 2 | 2 | 13.3 | 20 | 33.33 | |||
Grade 3 | 0 | 0 | 8 | 13.33 | |||
Grade 4 | 0 | 0 | 2 | 3.33 | |||
Total | 15 | 100 | 60 | 100 | |||
> 60 years | No HLN | 21 | 100 | 18 | 75 | 34.605 | < 0.001 |
Grade 1 | 0 | 0 | 4 | 16.7 | |||
Grade 2 | 0 | 0 | 2 | 8.3 | |||
Grade 3 | 0 | 0 | 0 | 0 | |||
Grade 4 | 0 | 0 | 0 | 0 | |||
Total | 21 | 100 | 24 | 100 | |||
Total | No HLN | 30 | 83.3 | 24 | 28.6 | 111.071 | < 0.001 |
Grade 1 | 4 | 11.1 | 28 | 33.3 | |||
Grade 2 | 2 | 5.6 | 22 | 26.2 | |||
Grade 3 | 0 | 0 | 8 | 9.5 | |||
Grade 4 | 0 | 0 | 2 | 2.4 | |||
Total | 36 | 100 | 84 | 100 | |||